En Es

Industry News

Global Digital Polymerase Chain Reaction (dPCR) Market Projected to Reach Close to USD 1.15 Billion by 2028

By Labmedica International staff writers
17 Sep 2021

IllustrationThe global digital polymerase chain reaction (dPCR) market is projected to grow at a CAGR of more than 9% from over USD 0.50 billion in 2020 to nearly USD 1.15 billion by 2028, driven primarily by rising infectious diseases, technological developments, as well as increased knowledge and acceptance of tailored treatments.

These are the latest findings of Valuates Reports (Karnataka, India), a market research company.

dPCR is a laboratory technique for making multiple copies of a specific piece of DNA from a sample with very small amounts of DNA. These fragments of DNA can be amplified and detected using PCR. It also provides for precise and sensitive nucleic acid measurement. It's also employed for absolute quantification and minority sequence analysis. The rise in the incidence of infectious diseases, as well as increased knowledge and acceptance of tailored treatments, are driving the expansion of the dPCR market. Furthermore, technological developments as a result of increased funding for R&D activities are likely to drive the dPCR market expansion during the forecast period.

The growth of the digital PCR market is expected to be fueled by the rising prevalence of infectious diseases and genetic disorders. As a result of its increasing use in the diagnosis of major infectious diseases and genetic disorders, the market for genomic analysis tools has gradually expanded over the last decade.

dPCR is more sensitive and clinically useful than real-time fluorogenic quantitative PCR. The typical PCR system is done by several microunits in dPCR, which greatly increases the PCR system's tolerance to inhibitors. Traditional PCR has a sensitivity of up to 1%, whereas dPCR has a sensitivity of up to 0.1%, and in certain cases as low as 0.001%, making it a perfect technique for trace DNA identification, uncommon mutation detection, and notably circulating tumor DNA detection. Furthermore, dPCR has been technologically upgraded to become a more operational and compatible tool, with highly understandable two-dimensional data. These advantages offered by dPCR are expected to drive market growth.

Even when only a small volume of sample is available, dPCR still achieves good accuracy, especially when identifying difficult-to-take samples or samples with the damaged nucleic acid. Clinical samples should be amplified when performing other genomic analyses, such as comparative genomic hybridization (CGH) chip or next-generation sequencing (NGS), to provide a large enough volume, but dPCR can be performed with a small number of samples, yielding reliable results by eliminating the error generating from preamplification. Thus, the ability to produce accurate results even with smaller sample size is increasing the adoption of dPCR, which in turn, is expected to drive market growth.

There have been numerous studies published since the COVID-19 pandemic in favor of dPCR for COVID-19 testing. Due to several variables such as higher sensitivity of ddPCR (Droplet Digital PCR), absence of inhibition from sample types, and simplicity of comprehending the data, there has been a considerable increase in the demand for ddPCR equipment and SARS-CoV-2 kits. Thus, the COVID-19 outbreak is expected to further propel the growth of the dPCR market.

Based on technology, the ddPCR segment dominated the dPCR market in 2020 and will maintain its lead over the forecast period. Its ability to accurately estimate DNA molecules with each drop made the ddPCR technique the leading revenue contributor to the dPCR market in 2020. Furthermore, a crucial component of the ddPCR technology is enormous sample splitting, which has increased its demand. Based on product type, the software & services segment is projected to exhibit the fastest growth during the forecast period, as software helps to improve the efficiency of management of dPCR data. Thus, there has been an increase in the demand for these products, thereby propelling the growth of the dPCR market.

Geographically, North America was the leading revenue contributor to the global dPCR market in 2020 and is expected to maintain its dominant position throughout the forecast period. This can be attributed to the region's well-developed healthcare industry, as well as the existence of prominent molecular diagnostics firms and an increase in the number of patients receiving tailored medicines. However, the Asia-Pacific dPCR market is expected to register the fastest CAGR of almost 14.50% during the forecast period due to an increase in the number of patients suffering from chronic diseases and improvement in healthcare facilities in the region, thereby providing lucrative opportunities for molecular diagnostics players.

Related Links:
Valuates Reports

E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

25 Nov 2021
Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases
The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic cases, technological developments in point of care devices and increased investments by the key players.
Read More
24 Nov 2021
Euromedlab Congress 2021 Postponed as Fourth COVID-19 Wave Hits Germany
The XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab Congress 2021) to be held as an in-presence meeting between 28th of November and 2nd of December in Germany has been postponed as the country has been hit very hard by a fourth wave of COVID-19.
Read More
19 Nov 2021
44th World Hospital Congress (WHC) Ends on Upbeat Note as Hospital Leaders Look to Build Resilience
The 44th World Hospital Congress (WHC) organized by The International Hospital Federation (IHF; Geneva, Switzerland) on 8-11 November 2021 in Barcelona, Spain came to an upbeat close.
Read More
16 Nov 2021
Deborah Bowen (USA) Takes Up Position of IHF President for 2021-2023
Deborah Bowen has taken up the position of President of the International Hospital Federation (IHF; Geneva, Switzerland) following her election in 2019 and a two-year term as President Designate.
Read More
16 Nov 2021
IHF and Deloitte Collaborate to Launch Special Interest Group on Leadership for Sustainability
The International Hospital Federation (IHF; Geneva, Switzerland) will collaborate with Deloitte (London, UK) to launch a special interest group (SIG) centered around leadership for sustainability.
Read More
16 Nov 2021
International Hospital Federation (IHF) Announces Winners of IHF Awards 2021
The International Hospital Federation (IHF; Geneva, Switzerland) announced the winners of the IHF Awards 2021 as part of a special ceremony at the 44th World Hospital Congress (WHC) held in Barcelona, Spain.
Read More
13 Nov 2021
GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health
General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023.
Read More
11 Nov 2021
Blood Borne Testing Market to Witness Exponential Growth Due to Rising Incidence of Bacterial Infections
The global blood borne testing market is projected to record an exponential CAGR of over 7-8% during 2021-2031, driven by increasing bacterial infection and growing adoption of point of care devices, aided further by technological advancement in devices for blood borne pathogens. These are the latest findings of Fact.MR (Dublin, Ireland), a market research firm.
Read More
10 Nov 2021
AI in Radiology Market Driven by Growing Adoption of Machine Learning Tools in Broad Spectrum of Imaging Applications
The use of AI algorithms in medical image analysis field has made astounding progress. Particularly deep learning has made incessant inroads in radiology practice. The major consumer proposition for companies in the AI in radiology market stems from the exceptional capabilities of AI tools in recognizing complex patterns in the imaging data. These are the latest findings of Transparency Market Research (Albany NY, USA).
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions